Last reviewed · How we verify

NCT03613935

Effect of Changes in Glucose Intake and Sweet Perception on Post Prandial Glycaemia

Completed NA Last updated 3 August 2018
What this trial tests

NA trial testing Product 1 in Healthy in 16 participants. Completed in 20 April 2018.

Timeline
19 February 2018
Primary endpoint
20 April 2018
20 April 2018

Quick facts

Lead sponsorSociété des Produits Nestlé (SPN)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment16
Start date19 February 2018
Primary completion20 April 2018
Estimated completion20 April 2018
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sugar-sweetened beverages are the main source of added sugars in most Westernized countries, and for this reason constitute a primary target for sugar reduction by many companies, including Nestlé. Instead of using high-intensity sweeteners which are non-caloric in nature, an alternative would be to reduce sugars without altering sweetness. In this protocol, the general goal is to investigate the relative contribution of sweet taste perception and sugar intake on post-prandial glucose response. 4 different nutritional products will be tested by 16 healthy subjects in a crossover design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03613935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing